PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway

In Vitro Cellular and Developmental Biology - Animal

Volumn 51, Issue 10, 2015, Pages 1047-1055

  Shi, Lei ^a,b   Fei, Xifeng ^c   Wang, Zhimin ^c   You, Yongping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

^c Suzhou Kowloon Hospital Affiliated with Shanghai Jiao Tong University School of Medicine   (China)

Author keywords

Glioblastoma; MiR 125b; Stem cells; Temozolomide

Indexed keywords

2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ALKYLATING AGENT; BETA CATENIN; CHROMONE DERIVATIVE; DACARBAZINE; MICRORNA; MIRN125 MICRORNA, HUMAN; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; TEMOZOLOMIDE; WNT PROTEIN;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CANCER STEM CELL; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; TUMOR CELL CULTURE; TUMOR INVASION; WNT SIGNALING PATHWAY;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BETA CATENIN; CELL MOVEMENT; CELL SURVIVAL; CHROMONES; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOBLASTOMA; HUMANS; MICRORNAS; MORPHOLINES; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PRIMARY CELL CULTURE; TUMOR CELLS, CULTURED; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84946403738     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-015-9931-x     Document Type: Article

References (24)

1. Atkins RJ, Dimou J, Paradiso L, Morokoff AP, Kaye AH, Drummond KJ, Hovens CM (2012) Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas. J Clin Neurosci 19(11):1558–1563
2. Baxter PA, Lin Q, Mao H, Kogiso M, Zhao X, Liu Z, Huang Y, Voicu H, Gurusiddappa S, Su JM, Adesina AM, Perlaky L, Dauser RC, Leung HC, Muraszko KM, Heth JA, Fan X, Lau CC, Man TK, Chintagumpala M, Li XN (2014) Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes. Acta Neuropathol Commun 2:160
3. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 190(6):1079–1091
4. Chang SF, Chang TK, Peng HH, Yeh YT, Lee DY, Yeh CR, Zhou J, Cheng CK, Chang CA, Chiu JJ (2009) BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21CIP1 and p27KIP1 regulation. Mol Endocrinol 23:1827–1838
5. Chen L, Han L, Shi Z, Zhang K, Liu Y, Zheng Y, Jiang T, Pu P, Jiang C, Kang C (2012) LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway. Mol Med Rep 5(2):575–579
6. Chen J, Fu X, Wan Y, Wang Z, Jiang D, Shi L (2014a) miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1. Tumour Biol 35:6293–6302
7. Chen X, Hu W, Xie B, Gao H, Xu C, Chen J (2014b) Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling. Biochem Biophys Res Commun 448(2):206–111
8. Darling JL (1990) The in vitro biology of human brain tumors, p. 1–25. In: Thomas DGT (ed) Neuro-oncology: primary malignant brain tumors. Johns Hopkins University Press, Baltimore
9. Gong A, Huang S (2012) FoxM1 and Wnt/β-catenin signaling in glioma stem cells. Cancer Res 72(22):5658–5662
10. Gong F, Wang G, Ye J, Li T, Bai H (2013) Wang W.14-3-3β regulates the proliferation of glioma cells through the GSK-3β/β-catenin signaling pathway. Oncol Rep 30(6):2976–2982
11. Guo M, Zhang X, Wang G, Sun J, Jiang Z, Khadarian K, Yu S, Zhao Y, Xie C, Zhang K, Zhu M, Shen H, Lin Z, Jiang C, Shen J, Zheng Y (2015) miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1. Cancer Lett 360(1):76–86
12. Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, Nakano-Okuno M, Taylor D, Minata M, Sulman EP, Lee J, Bhat KP, Salcini AE, Nakano I (2015) EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem Cell Rep 4(2):226–238
13. Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, Joo KM, Lee J, Nam DH (2013) Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol 15(2):161–171
14. Liu J, Han G, Liu H, Qin C (2013) Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling. PLoS One 8(4):e62844
15. Liu J, Liu L, Xue Y, Meng F, Li S, Wang P, Liu Y (2014) Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells. Biochem Pharmacol 89:477–489
16. Mendiburu-Eliçabe M, Gil-Ranedo J, Izquierdo M (2014) Efficacy of rapamycin against glioblastoma cancer stem cells. Clin Transl Oncol 16(5):495–502
17. Sabo B (2014) Primary malignant brain tumours, psychosocial distress and the intimate partner experience: what do we know? Can J Neurosci Nurs 36:9–15
18. Sai K, Li WY, Chen YS, Wang J, Guan S, Yang QY, Guo CC, Mou YG, Li WP, Chen ZP (2014) Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells. Am J Chin Med 42:485–503
19. Shi L, Wan Y, Sun G, Zhang S, Wang Z, Zeng Y (2014) miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. BioDrugs 28(1):41–54
20. Shi L, Wang Z, Sun G (2015) Curcumin induces glioma stem-like cell formation. Neuroreport 26:167–172
21. Wan Y, Sun G, Zhang S, Wang Z, Shi L (2013) MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion. In Vitro Cell Dev Biol Anim 49(8):599–607
22. Wang F, Xiao W, Sun J, Han D, Zhu Y (2014) MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma. Tumour Biol 35:8653–8658
23. Wang G, Dai F, Yu K, Jia Z, Zhang A, Huang Q, Kang C, Jiang H, Pu P (2015) Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways. Int J Oncol 46:1739–1747
24. Zhang K, Zhu S, Liu Y, Dong X, Shi Z, Zhang A, Liu C, Chen L, Wei J, Pu P, Zhang J, Jiang T, Han L, Kang C (2015) ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity. Cancer Lett 357(1):404–411